| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 药品收入(元) | 208,399,058.95 | 753,328,147.40 | 370,715,901.20 | 774,117,233.84 | 199,121,892.85 |
| 医疗收入(元) | 1,378,052,751.10 | 3,036,460,891.07 | 1,443,625,958.14 | 2,806,334,263.40 | 1,400,933,403.02 |
| 其他产品(元) | - | 9,221,274.93 | - | 10,030,562.83 | 6,668,069.11 |
| 营业成本(元) | |||||
| 药品收入(元) | 123,652,292.17 | 380,562,192.68 | 200,708,807.20 | 431,178,072.39 | 58,365,535.34 |
| 医疗收入(元) | 1,012,658,116.81 | 2,236,930,157.75 | 1,086,788,884.16 | 2,066,534,728.56 | 1,018,570,181.12 |
| 其他产品(元) | - | 6,518,418.25 | - | 12,842,767.24 | 2,168,987.75 |
| 毛利(元) | |||||
| 药品收入(元) | 84,746,766.78 | 372,765,954.72 | 170,007,094.00 | 342,939,161.45 | 140,756,357.51 |
| 医疗收入(元) | 365,394,634.29 | 799,530,733.32 | 356,837,073.98 | 739,799,534.84 | 382,363,221.90 |
| 其他产品(元) | - | 2,702,856.68 | - | -2,812,204.41 | 4,499,081.36 |
| 毛利率(%) | |||||
| 药品收入(%) | 40.67 | 49.48 | 45.86 | 44.30 | 70.69 |
| 医疗收入(%) | 26.52 | 26.33 | 24.72 | 26.36 | 27.29 |
| 其他产品(%) | - | 29.31 | - | -28.04 | 67.47 |
| 收入构成(%) | |||||
| 药品收入(%) | 13.14 | 19.83 | 20.43 | 21.56 | 12.39 |
| 医疗收入(%) | 86.86 | 79.93 | 79.57 | 78.16 | 87.19 |
| 其他产品(%) | - | 0.24 | - | 0.28 | 0.42 |
| 毛利构成(%) | |||||
| 药品收入(%) | 18.83 | 31.72 | 32.27 | 31.76 | 26.68 |
| 医疗收入(%) | 81.17 | 68.05 | 67.73 | 68.50 | 72.47 |
| 其他产品(%) | - | 0.23 | - | -0.26 | 0.85 |